**Morphologic interpretation:** The peripheral blood smear demonstrates a high proportion of blasts, predominantly myeloblasts, with a blast percentage exceeding 88%, consistent with acute myeloid leukemia (AML). Lymphoblasts and monoblasts are also present, but in lesser numbers, and the presence of mature neutrophils, lymphocytes, and monocytes suggests a mixed cellular population. The myeloblasts exhibit characteristic features including basophilic cytoplasm and prominent nuclear chromatin, while lymphoblasts show a more rounded nucleus and less cytoplasmic basophilia. The presence of promonocytes and monocytes further supports the myeloid lineage origin.

**Diagnostic flags:** blasts_present; blast_threshold_met

**Impression:** AML

**Differential considerations:**
- The high blast percentage and predominance of myeloblasts are consistent with AML, but the presence of lymphoblasts and monoblasts may suggest a mixed lineage or a variant such as AML with myelodysplasia or AML with monocytic features.
- The presence of mature neutrophils and lymphocytes indicates a non-lymphoid or non-myeloid origin, which may be consistent with a myelodysplastic syndrome or a secondary AML.
- The presence of promonocytes and monocytes may suggest a myelodysplastic syndrome or a variant of AML with monocytic features.

**Recommended workup:**
- Perform a bone marrow biopsy to confirm the diagnosis and assess for myelodysplasia or other secondary changes.
- Conduct a cytogenetic analysis to identify any chromosomal abnormalities that may be associated with AML.
- Perform a flow cytometry analysis to determine the immunophenotype and rule out other hematologic malignancies.
- Consider a molecular analysis for mutations such as FLT3, NPM1, or TP53, which may be associated with AML and guide treatment decisions.

## Quantitative Cell Summary

- Fields of view: 59
- Detected cells: 219
- Informative WBCs: 133
- Artefacts/non-WBC detections: 86

| Cell type | Count | % informative WBCs |
|---|---:|---:|
| Myeloblast | 80 | 60.2% |
| Lymphoblast | 20 | 15.0% |
| Monoblast | 17 | 12.8% |
| Neutrophil | 8 | 6.0% |
| Lymphocyte | 4 | 3.0% |
| Promonocyte | 2 | 1.5% |
| Eosinophil | 1 | 0.8% |
| Monocyte | 1 | 0.8% |

## Agentic Diagnosis
Predicted diagnosis: **AML** (confidence 0.86). Rationale: learned classifier prediction from detection-derived features.

## Cell Grounding

- `img000_c000` in `15_10_1000_AML.png` bbox=[40.62, 119.0, 115.38, 254.5]: Myeloblast (0.94); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img002_c000` in `15_12_1000_AML.png` bbox=[467.5, 104.75, 524.5, 197.5]: Lymphoblast (0.92); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img002_c001` in `15_12_1000_AML.png` bbox=[0.0, 450.5, 41.62, 549.0]: Myeloblast (0.74); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img002_c002` in `15_12_1000_AML.png` bbox=[0.0, 452.0, 41.59, 549.0]: Lymphoblast (0.58); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img002_c003` in `15_12_1000_AML.png` bbox=[250.88, 503.0, 329.0, 639.0]: Myeloblast (0.48); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img003_c000` in `15_14_1000_AML.png` bbox=[576.0, 455.5, 640.0, 577.5]: Neutrophil (0.93); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img003_c001` in `15_14_1000_AML.png` bbox=[34.25, 384.0, 112.62, 518.0]: Myeloblast (0.92); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img003_c003` in `15_14_1000_AML.png` bbox=[67.12, 105.0, 136.38, 222.75]: Myeloblast (0.85); nuclear chromatin; nuclear shape; nucleus; cytoplasm.

> **⚠ Flagged for mandatory human review by the reflection agent.** Reason(s): High pct_class_none and low mean detection confidence suggest data quality issues despite high blast burden.
